Usefulness of New Quick Cortisol Assay during Adrenal Vein Sampling in Patients with Primary Aldosteronism

Usefulness of New Quick Cortisol Assay during Adrenal Vein Sampling in Patients with Primary Aldosteronism - New Quick Cortisol Assay during Adrenal Vein Sampling

Status

Active, not recruiting

Phases

Unknown

Study type

Interventional

Source

JPRN

Registry ID

JPRN-UMIN000007440

Enrollment

400

Registered

2012-03-05

Start date

2011-12-01

Completion date

Unknown

Last updated

2026-06-29

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Primary aldosteronism

Interventions

traditional AVS AVS using quick cortisol assay

Eligibility

Sex/Gender

All

Inclusion criteria

Inclusion criteria: Patients with primary aldosteronism who are candidtes for surgery

Exclusion criteria

Exclusion criteria: 1)patients with primary aldosteronism who are not candidtes for surgery 2)patients under dialysis or with serum creatinine >2.5 mg/dl in men or >2.0 mg/dl in women 3)pregnancy or breast feeding 4)with malignancy 5)with severe hypersensitivity or with corticoid therapy 6)inadequacy to participate in the study, as assessed by the investigators

Design outcomes

Primary

Measure	Time frame
Success rate of AVS	—

Secondary

Measure	Time frame
1)effects on differential diagnosis of PA. 2)effects on turn-round time of AVS. 3)rares of complications 4)cost for new quick cortisol assay	—

Countries

Japan

Contacts

Public ContactTakashi Yoneda

Kanazawa University Graduate School of Medical Science Department of internal medicine

endocrin@med.kanazawa-u.ac.jp076-265-2252

Outcome results

None listed

Source: JPRN (via WHO ICTRP) · Data processed: Jul 3, 2026